Antinucleosome antibodies in SLE: A two-year follow-up study of 101 patients

Journal of Autoimmunity

Volumn 22, Issue 3, 2004, Pages 235-240

  Ghirardello, A ^a   Doria, A ^a   Zampieri, S ^a   Tarricone, E ^a   Tozzoli, R ^b   Villalta, D ^c   Bizzaro, N ^d   Piccoli, A ^a   Gambari, P F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Clin Chem and Microbiology Unit   (Italy)

^c AO S Maria degli Angeli   (Italy)

^d AULSS 12   (Italy)

Author keywords

Anti dsDNA antibody; Antinucleosome antibody; Nephritis; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; ANTIBODIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NUCLEOSOMES; SERUM;

EID: 1642286027     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2003.12.005     Document Type: Article

References (39)

1. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
2. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1997;1725.
3. Amital H., Shoenfeld Y. Nucleosomes, DNA and SLE: where is the starting point? Clin Exp Rheumatol. 14:1996;475-477.
4. Stollar B.D. Antibodies to DNA. CRC Crit Rev Biochem. 20:1986;1-36.
5. Brard F., Jovelin F., Petit S., Tron F., Gilbert D. Structural properties and mutation patterns of anti-nucleosome monoclonal antibodies are similar to those of anti-DNA antibodies. Eur J Immunol. 26:1996;1587-1594.
6. Hahn B.H. Antibodies to DNA. N Eng J Med. 338:1998;1359-1368.
7. Mohan C., Morel L., Yang P., Watanabe H., Croker B., Gilkeson G., et al. Genetic dissection of lupus pathogenesis: a recipe for nephrolitic autoantibodies. J Clin Invest. 103:1999;1685-1695.
8. Friedmann D., Yachimovich N., Mostoslavsky G., Pewzner-Jung Y., Ben-Yehuda A., Rajewsky K., et al. Production of high affinity autoantibodies in autoimmune New Zealand black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J Immunol. 162:1999;4406-4416.
9. Pyun E.H., Pisetsky D.S., Gilkeson G.S. The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. J Autoimmun. 6:1993;11-26.
10. Desai D.D., Krishnan M.R., Swindle J.T., Marion T.N. Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol. 151:1993;1614-1626.
11. Amoura Z., Piette J.C., Chabre E., Cacoub P., Papo T., Wechsler B., et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 40:1997;2217-2225.
12. Mohan C., Adams S., Stanik V., Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 177:1993;1367-1381.
13. Emlen W., Neibur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 152:1994;3685-3692.
14. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;1241-1250.
15. Van Ghelue M., Moens U., Bendiksen S., Rekvig O.P. Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation. J Autoimmun. 20:2003;171-182.
16. Amoura Z., Chabre H., Koutouzov S., Lotton C., Cabrespines A., Bach J.-F., et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37:1994;1684-1688.
17. Kramers C., Hylkema M.N., van Bruggen M.C.J., van de Lagermaat R., Dijkman H.B.P.M., Assmann K.J., et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNAreactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest. 94:1994;568-577.
18. Termaat R.M., Brinkman K., Gompel F.V., van den Heuvel L.P., Veerkamp J.H., Smeenk R.J., et al. Crossreactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun. 3:1990;531-538.
19. Berden J.H., Licht R., van Bruggen M.C., Tax W.J. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens. 8:1999;299-306.
20. Grootscholten C., van Bruggen M.C.J., van der Pijl J.W., de Jong E.M.G.J., Ligtenberg G., Derksen R.H.W.M., et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum. 48:2003;1355-1362.
21. Vitali C., Bencivelli W., Isenberg D.A., Smolen J.S., Snaith M.L., Sciuto M., et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol. 10:1992;541-547.
22. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum. 39:1996;363-369.
23. Burlingame R.W., Rubin R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods. 134:1990;187-199.
24. Sox H.C., Blatt M.A., Higgins M.C., Marton K.J. Medical decision making. 1988;130-138 Butterworth-Heinemann, Boston.
25. Villalta D., Romelli P.B., Savina C., Bizzaro N., Tozzoli R., Tonutti E., et al. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus. 12:2003;31-36.
26. Dixon W.J., Brown M.B., Engelman L., Jennrich R.I. BMDPstatistical software manual. 1990;Berkeley (CA), UCLA.
27. Rekvig O.P., Nossent J.C. Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus. A time for new paradigms? Arthritis Rheum. 48:2003;300-312.
28. Laderach D., Koutouzov S., Bach J., Yamamoto A.M. Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice. J Autoimmun. 20:2003;161-170.
29. Burlingame R.W., Boey M.L., Starkebaum G., Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 94:1994;184-192.
30. Amoura Z., Koutouzov S., Chabre H., Cacoub P., Amoura I., Musset L., et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum. 43:2000;76-84.
31. Bruns A., Blass S., Hausdorf G., Burmester G.R., Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43:2000;2307-2315.
32. Min D.J., Kim S.J., Park S.H., Seo Y.I., Kang H.J., Kim W.U., et al. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol. 20:2002;13-18.
33. Cairns A.P., McMillan S.A., Crockard A.D., Meenagh G.K., Duffy E.M., Armstrong D.J., et al. Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis. 62:2003;272-273.
34. Wallace D.J., Lin H.-C., Shen G.Q., Peter J.B. Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis Rheum. 37:1994;1795-1797.
35. Hmida Y.B.H., Schmit P., Gilson G., Humbel R.-L. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum. 46:2002;280-282.
36. Hasegawa M., Sato S., Kikuchi K., Takehara K. Antigen specificity of antihistone antibodies in systemic sclerosis. Ann Rheum Dis. 57:1998;470-475.
37. Palmer D.K., O'Day K., Charbonneau H., Margolis R.L. Purification of the centromere-specific protein CENP-A and demonstration that it is a distinctive histone. Proc Natl Acad Sci U S A. 88:1991;3734-3738.
38. Chabre H., Amoura Z., Piette J.-C., Godeau P., Bach J.-F., Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 38:1995;1485-1491.
39. Hylkema M.N., van Bruggen M.C.J.V., ten Hove T., de Jong J., Swaak A.J., Berden J.H., et al. Histone-containing immune complexes are to a large extent responsible for anti-ds-DNA reactivity in the Farr assay of active patients. J Autoimmun. 14:2000;159-168.